原文 | 英語 |
---|---|
頁(從 - 到) | 588-591 |
頁數 | 4 |
期刊 | Nature Methods |
卷 | 18 |
發行號 | 6 |
DOIs |
|
出版狀態 | 已發佈 - 6月 2021 |
ASJC Scopus subject areas
- 生物技術
- 生物化學
- 分子生物學
- 細胞生物學
引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
於: Nature Methods, 卷 18, 編號 6, 06.2021, p. 588-591.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
}
TY - JOUR
T1 - Diversity in immunogenomics
T2 - the value and the challenge
AU - Peng, Kerui
AU - Safonova, Yana
AU - Shugay, Mikhail
AU - Popejoy, Alice B.
AU - Rodriguez, Oscar L.
AU - Breden, Felix
AU - Brodin, Petter
AU - Burkhardt, Amanda M.
AU - Bustamante, Carlos
AU - Cao-Lormeau, Van Mai
AU - Corcoran, Martin M.
AU - Duffy, Darragh
AU - Fuentes-Guajardo, Macarena
AU - Fujita, Ricardo
AU - Greiff, Victor
AU - Jönsson, Vanessa D.
AU - Liu, Xiao
AU - Quintana-Murci, Lluis
AU - Rossetti, Maura
AU - Xie, Jianming
AU - Yaari, Gur
AU - Zhang, Wei
AU - Abedalthagafi, Malak S.
AU - Adekoya, Khalid O.
AU - Ahmed, Rahaman A.
AU - Chang, Wei Chiao
AU - Gray, Clive
AU - Nakamura, Yusuke
AU - Lees, William D.
AU - Khatri, Purvesh
AU - Alachkar, Houda
AU - Scheepers, Cathrine
AU - Watson, Corey T.
AU - Karlsson Hedestam, Gunilla B.
AU - Mangul, Serghei
N1 - Funding Information: We thank Nicky Mulder for comments that greatly improved the manuscript. Y.S. was supported by the National Science Foundation EAGER award (no. 2032783). M.S. is supported by Ministry of Science and Higher Education of the Russian Federation grant no. 075-15-2020-807. A.B.P. and C.D.B. are supported by an award from the National Human Genome Research Institute of the National Institutes of Health (U41HG009649). C.T.W. and O.L.R. are supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R24AI138963 and R21AI142590. V.G. is supported by a UiO World-Leading Research Community grant, the UiO:LifeScience Convergence Environment Immunolingo, EU Horizon 2020 iReceptorplus (no. 825821) and a Research Council of Norway FRIPRO project (#300740). V.D.J. was supported by an award from the National Cancer Institute of the National Institutes of Health (K12CA001727). The laboratory of L.Q.-M. is supported by the Institut Pasteur, the Collège de France, the CNRS, the Fondation Allianz-Institut de France and the French Government’s Investissement d’Avenir program, Laboratoires d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (ANR-10-LABX-62-IBEID) and ‘Milieu Intérieur’ (ANR-10-LABX-69-01). R.A.A. is supported by the Fogarty International Center of the National Institute of Health under award number D43TW010934. P.K. is supported by the Bill and Melinda Gates Foundation (OPP1113682), National Institute of Allergy and Infectious Diseases (NIAID) (1U19AI109662, U19AI057229, 5R01AI125197), Department of Defense (W81XWH1910235) and Catalyst and Transformational Awards from the Dr. Ralph & Marian Falk Medical Research Trust. C.S. is supported by NIAID of the National Institutes of Health under award number U01AI136677. G.K.H is supported by a grant from the Swedish Research Council (award number 532 2017-00968). S.M. is partially supported by National Science Foundation grants 2041984.
PY - 2021/6
Y1 - 2021/6
UR - http://www.scopus.com/inward/record.url?scp=85105909487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105909487&partnerID=8YFLogxK
U2 - 10.1038/s41592-021-01169-5
DO - 10.1038/s41592-021-01169-5
M3 - Comment/debate
C2 - 34002093
AN - SCOPUS:85105909487
SN - 1548-7091
VL - 18
SP - 588
EP - 591
JO - Nature Methods
JF - Nature Methods
IS - 6
ER -